HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M Dietrich Selected Research
M Dietrich Research Topics
Disease
3
Falciparum Malaria (Plasmodium falciparum Malaria)
04/2001 - 01/2000
2
Critical Illness (Critically Ill)
06/2022 - 01/2021
2
Neoplasms (Cancer)
12/2014 - 03/2004
2
Thrombosis (Thrombus)
03/2004 - 12/2002
2
Hepatitis
11/2001 - 01/2001
1
Convalescence
07/2022
1
COVID-19
06/2022
1
Penile Neoplasms (Penile Cancer)
04/2018
1
Triple Negative Breast Neoplasms
12/2014
1
Breast Neoplasms (Breast Cancer)
12/2014
1
Diverticulitis
01/2010
1
Cardiovascular Diseases (Cardiovascular Disease)
08/2009
1
Hemorrhage
10/2006
1
Neutropenia
03/2004
1
Thrombocytopenia 3
03/2004
1
Anemia
03/2004
1
Fever (Fevers)
03/2004
1
Nausea
03/2004
1
Pancreatic Neoplasms (Pancreatic Cancer)
03/2004
1
Vomiting
03/2004
1
Body Weight (Weight, Body)
01/2004
1
Long Term Adverse Effects
07/2003
1
Acquired Immunodeficiency Syndrome (AIDS)
07/2003
1
Hepatitis B
01/2002
1
Hepatitis A (Hepatitis, Infectious)
01/2002
1
Persistent Infection
11/2001
1
Needlestick Injuries (Needlestick Injury)
11/2001
1
Hepatitis C
11/2001
1
Infections
11/2001
1
Atrial Heart Septal Defects (Atrial Septal Defect)
09/2001
1
Cicatrix (Scar)
05/2001
1
Parasitemia
07/2000
1
Acute malaria
07/2000
1
Carcinoma (Carcinomatosis)
01/2000
1
Malaria
01/2000
Drug/Important Bio-Agent (IBA)
1
Everolimus
FDA Link
12/2014
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2014
1
Docetaxel (Taxotere)
FDA Link
12/2014
1
Anthracyclines
IBA
12/2014
1
Epirubicin (Ellence)
FDA Link
Generic
12/2014
1
taxane
IBA
12/2014
1
Bevacizumab (Avastin)
FDA Link
12/2014
1
Vitamin E
FDA Link
Generic
08/2009
1
Irinotecan (Camptosar)
FDA Link
Generic
03/2004
1
Gemcitabine
FDA Link
03/2004
1
Antiemetics
IBA
03/2004
1
Cisplatin (Platino)
FDA Link
Generic
03/2004
1
Leucovorin (Folinic Acid)
FDA Link
03/2004
1
Fluorouracil (Carac)
FDA Link
Generic
03/2004
1
Carbon Dioxide
IBA
01/2004
1
Biological Products
IBA
01/2002
1
Vaccines
IBA
01/2002
1
Antigens
IBA
01/2002
1
twinrix
IBA
01/2002
1
Combined Vaccines
IBA
01/2002
1
Hepatitis A Antibodies
IBA
01/2002
1
Pharmaceutical Preparations
IBA
11/2001
1
Interferon alpha-2 (Roferon-A)
FDA Link
11/2001
1
Collagen Type I (Type I Collagen)
IBA
05/2001
1
Keratins (Keratin)
IBA
05/2001
1
Procalcitonin
IBA
04/2001
1
Neopterin
IBA
07/2000
1
CTLA-4 Antigen
IBA
07/2000
1
Fas Ligand Protein (Fas Ligand)
IBA
05/2000
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
01/2000
1
Messenger RNA (mRNA)
IBA
01/2000
1
Nitric Oxide Synthase (NO Synthase)
IBA
01/2000
1
RNA (Ribonucleic Acid)
IBA
01/2000
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
01/2000
Therapy/Procedure
4
Therapeutics
01/2021 - 01/2000
2
Critical Care (Surgical Intensive Care)
06/2022 - 01/2021
2
Highly Active Antiretroviral Therapy (HAART)
07/2003 - 01/2001
1
Enhanced Recovery After Surgery
07/2022
1
Surgical Amputation (Amputations)
04/2018
1
Neoadjuvant Therapy
12/2014
1
Laparotomy
01/2010
1
Colectomy
01/2010
1
Artificial Respiration (Mechanical Ventilation)
10/2006
1
Thrombectomy
12/2002
1
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
12/2002
1
Septal Occluder Device
09/2001